Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
Fiscal Year 2023 Omnibus Summary
COVID-19 Emergency Declaration Timeline
The Facts About COVID-19 and Children
Fiscal Year 2023 Omnibus Summary
This detailed summary of the FY 2023 Omnibus focuses on those provisions of most interest to children’s hospitals.
COVID-19 Emergency Declaration Timeline
This chart contains updated information on the various COVID-19 emergency declarations, including timelines, processes for renewal and current expiration dates.
The Facts About COVID-19 and Children
Read the latest data on kids' COVID-19 cases, hospitalizations and vaccination numbers.
